News

Telepsychiatry effective for ADHD treatment in rural areas


 

AT THE AACAP ANNUAL MEETING

ORLANDO – Telepsychiatry in rural areas is beneficial for children with attention-deficit/hyperactivity disorder and their parents, according to one of the largest randomized controlled trials of its kind.

During the 22 weeks of the study, children who received telemental health (TMH) improved significantly in ADHD inattention and hyperactivity, oppositional defiant disorder, school performance, and adaptive functioning, based on the ratings provided by their parents.

Dr. William P. French

The study is yet another piece of evidence that telemedicine can play a role in closing the mental health gap.

"Our study shows that with modern technology, we have the opportunity to reach out to underserved areas and provide care," said Dr. William P. French of the University of Washington, Seattle. "And the care is good care and can improve the health of the patients at least as well as the local providers."

Dr. French and his colleagues used the Children’s ADHD Telemental Health Treatment Study, or CATTS, to assess the impact of telemental health on children’s inattention, hyperactivity, opposition, school performance, and impairment. They also evaluated the telepsychiatrists’ and therapists’ adherence to evidence-based treatment protocols implemented within the TMH model.

CATTS includes 223 English-speaking children aged 5.5-12 years with ADHD, along with their parents. The children were recruited from several local primary care practices in seven rural areas in Washington and Oregon between November 2009 and August 2012.

The children were randomly assigned to two groups. Group A, or the intervention group, received six teleconferencing sessions over a 22-week period. Their medication and education were delivered via videoconferencing by a child and adolescent psychiatrist. Their parents’ behavior training, which also occurred in six sessions, was provided in person by a community therapist. The local therapists already had been trained in treatment protocols and were supervised remotely.

Group B, or the active control group, received one video conferencing session with the child and adolescent psychiatrist, who gave the primary care providers treatment recommendations. For the rest of the trial period, this group received the standard of care, which was mainly treatment by their primary care provider.

The primary outcome included the Vanderbilt ADHD Rating Scales (VADRS) and the Columbia Impairment Scale–Parent Version (CIS-P), both of which were filled out by parents. Teachers assessed the ADHD and oppositional defiant disorder symptoms using VADRS.

Assessments were conducted at baseline, 4, 10, and 19 weeks, and at 25 weeks post randomization.

Results showed that during the 22 weeks, children receiving TMH had significantly better responses than the control group, the researchers found. Their parent-rated ADHD inattention and hyperactivity, oppositional defiant disorder, school performance, and adaptive functioning improved, as did their teacher-rated ADHD inattention and school performance.

However, no effect was shown in the teacher-rated hyperactivity or oppositional defiant disorder. Dr. French said this could be attributable to the contextual demands of school versus home, or a change in teacher with kids moved to the next grade during the study period.

The study also showed that telepsychiatrists and therapists adhered to the evidence-based treatment protocols more than 90% of the time. Researchers said that TMH can be effective in training community therapists in evidence-based treatment behavioral management.

Barriers still exist to widespread implementation and adoption of telepsychiatry– with privacy concerns and lack of reimbursement just to name two – but advancement in technology is making the service more readily available, said Dr. French, who presented his findings in a poster at the American Academy of Child and Adolescent Psychiatry meeting.

"Telemedicine is going to be mostly Internet based," he said, "and this opens the potential to anyone with Internet access and a mobile device that has a camera and audio capabilities."

The study was supported by the National Institute of Mental Health. Researchers reported no relevant financial disclosures.

nmiller@frontlinemedcom.com

On Twitter @naseemsmiller

Recommended Reading

Teens report increasingly lax attitude about marijuana use
MDedge Psychiatry
FDA warns methylphenidate drugs associated with priapism
MDedge Psychiatry
Exposure therapy trumped supportive counseling for adolescent PTSD
MDedge Psychiatry
Ohio Medicaid data document rising polypharmacy in foster children
MDedge Psychiatry
Perception of safety spurs e-cigarette use in young adults
MDedge Psychiatry
When ADHD doesn’t improve, check medication adherence first
MDedge Psychiatry
Drug therapy for children with autism: No magic bullets yet
MDedge Psychiatry
For trichotillomania, try behavioral therapy before drugs
MDedge Psychiatry
Revised autism screening tool more accurate
MDedge Psychiatry
Treating childhood anxiety requires patience, persistence
MDedge Psychiatry